The DOI matches its Crossref record; 97 of the 97 references it cites were found in a registry or an index.
Current and Future Treatment of Hepatocellular Carcinoma: An Updated Comprehensive Review
Open accessAbstract
Hepatocellular carcinoma (HCC) is among the leading causes of cancer-related mortality. The principal treatment is surgical resection or liver transplantation, depending on whether the patient is a suitable transplant candidate. However, in most patients with HCC the diagnosis is often late, thereby excluding the patients from definitive surgical resection. Medical treatment includes sorafenib, which is the most commonly used systemic therapy; although, it has been shown to only minimally impact patient survival by several months. Chemotherapy and radiotherapy are generally ineffective. Due to the poor prognosis of patients with HCC, newer treatments are needed with several being in development, either in pre-clinical or clinical studies. In this review article, we provide an update on the current and future medical and surgical management of HCC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Ferlay, J., Shin, H., Bray, F., Forman, D., Mathers, C., & Parkin, D. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25516 · Cited by 21,293
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
Hodi, F. S., O'Day, S. J., McDermott, D. F., Weber, R. W., Sosman, J. A., Haanen, J. B., Gonzalez, R., Robert, C., Schadendorf, D., Hassel, J. C., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003466 · Cited by 15,155
Sorafenib in advanced hepatocellular carcinoma
Llovet, J. M., Ricci, S., Mazzaferro, V., Hilgard, P., Gane, E., Blanc, J.-F., de Oliveira, A. C., Santoro, A., Raoul, J.-L., Forner, A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708857 · Cited by 13,097
Management of Hepatocellular Carcinoma: An Update Δσ
Bruix, J., & Sherman, M. (2011) · Hepatology · doi:10.1002/hep.24199 · Cited by 8,103
Mazzaferro, V., Regalia, E., Doci, R., Andreola, S., Pulvirenti, A., Bozzetti, F., Montalto, F., Ammatuna, M., Morabito, A., & Gennari, L. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603143341104 · Cited by 7,186
A New Era of Systemic Therapy for Hepatocellular Carcinoma with Regorafenib and Lenvatinib
Kudo, M. (2017) · Liver Cancer · doi:10.1159/000462153 · Cited by 5,936
Acute Abdomen: A Rare Case of Ruptured Hepatocellular Carcinoma
Gloor, S., Jensen, K. O., Breitenstein, S., Binkert, C. A., Angst, E., & Hetzer, F. H. (2017) · Case Reports in Gastroenterology · doi:10.1159/000463378 · Cited by 5,370
EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
European Association for the Study of the Liver, & European Organisation for Research and Treatment of Cancer (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.12.001 · Cited by 5,218
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
Dong, H., Strome, S. E., Salomao, D. R., Tamura, H., Hirano, F., Flies, D. B., Roche, P. C., Lu, J., Zhu, G., Tamada, K., et al. (2002) · Nature Medicine · doi:10.1038/nm730 · Cited by 5,025
El-Khoueiry, A. B., Sangro, B., Yau, T., Crocenzi, T. S., Kudo, M., Hsu, C., Kim, T.-Y., Choo, S.-P., Trojan, J., Welling, T. H., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31046-2 · Cited by 4,280
Llovet, J. M., & Bruix, J. (2003) · Hepatology · doi:10.1053/jhep.2003.50047 · Cited by 3,029
Primary liver cancer: Worldwide incidence and trends
Bosch, F. X., Ribes, J., Díaz, M., & Cléries, R. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.011 · Cited by 2,477
Yao, F. Y., Ferrell, L., Bass, N. M., Watson, J. J., Bacchetti, P., Venook, A., Ascher, N. L., & Roberts, J. P. (2001) · Hepatology · doi:10.1053/jhep.2001.24563 · Cited by 2,262
Wilhelm, S. M., Adnane, L., Newell, P., Villanueva, A., Llovet, J. M., & Lynch, M. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0013 · Cited by 1,459
Schnitzbauer, A. A., Lang, S. A., Goessmann, H., Nadalin, S., Baumgart, J., Farkas, S. A., Fichtner-Feigl, S., Lorf, T., Goralcyk, A., Hörbelt, R., et al. (2012) · Annals of Surgery · doi:10.1097/sla.0b013e31824856f5 · Cited by 1,332
Livraghi, T., Solbiati, L., Meloni, M. F., Gazelle, G. S., Halpern, E. F., & Goldberg, S. N. (2003) · Radiology · doi:10.1148/radiol.2262012198 · Cited by 1,298
Tissue Ablation with Irreversible Electroporation
Davalos, R. V., Mir, L. M., & Rubinsky, B. (2005) · Annals of Biomedical Engineering · doi:10.1007/s10439-005-8981-8 · Cited by 1,293
Hepatocellular carcinoma: a global view
Yang, J. D., & Roberts, L. R. (2010) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.100 · Cited by 1,286
EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
(2012) · European Journal of Cancer · doi:10.1016/j.ejca.2011.12.021 · Cited by 1,096
Salem, R., Lewandowski, R. J., Mulcahy, M. F., Riaz, A., Ryu, R. K., Ibrahim, S., Atassi, B., Baker, T., Gates, V., Miller, F. H., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.09.006 · Cited by 1,074
Self-citationBelghiti, J., Hiramatsu, K., Benoist, S., Massault, P. P., Sauvanet, A., & Farges, O. (2000) · Journal of the American College of Surgeons · doi:10.1016/s1072-7515(00)00261-1 · Cited by 1,051
Strategies for Safer Liver Surgery and Partial Liver Transplantation
Clavien, P.-A., Petrowsky, H., DeOliveira, M. L., & Graf, R. (2007) · New England Journal of Medicine · doi:10.1056/nejmra065156 · Cited by 1,022
Sangro, B., Gomez-Martin, C., de la Mata, M., Iñarrairaegui, M., Garralda, E., Barrera, P., Riezu-Boj, J. I., Larrea, E., Alfaro, C., Sarobe, P., et al. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.02.022 · Cited by 980
Tobacco smoking and cancer: A meta‐analysis
Gandini, S., Botteri, E., Iodice, S., Boniol, M., Lowenfels, A. B., Maisonneuve, P., & Boyle, P. (2008) · International Journal of Cancer · doi:10.1002/ijc.23033 · Cited by 971
The Incidence and Epidemiology of Hepatocellular Carcinoma: A Global and Regional Perspective
Venook, A. P., Papandreou, C., Furuse, J., & Ladrón de Guevara, L. (2010) · The Oncologist · doi:10.1634/theoncologist.2010-s4-05 · Cited by 965
Resection and Liver Transplantation for Hepatocellular Carcinoma
Llovet, J. M., Schwartz, M., & Mazzaferro, V. (2005) · Seminars in Liver Disease · doi:10.1055/s-2005-871198 · Cited by 879 · cited 1×
“However, recent studies have reported a low mortality rate of less than 5% in cases of cirrhosis without evidence of portal hypertension.(106,107) Due to the high rate of disease recurrence, the 5-year survival rates after partial hepatectomy for HCC range between 60% and 70%.”
BackgroundGao, Q., Wang, X.-Y., Qiu, S.-J., Yamato, I., Sho, M., Nakajima, Y., Zhou, J., Li, B.-Z., Shi, Y.-H., Xiao, Y.-S., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1608 · Cited by 813
Oncolytic virus therapy: A new era of cancer treatment at dawn
Fukuhara, H., Ino, Y., & Todo, T. (2016) · Cancer Science · doi:10.1111/cas.13027 · Cited by 774
Ishizawa, T., Hasegawa, K., Aoki, T., Takahashi, M., Inoue, Y., Sano, K., Imamura, H., Sugawara, Y., Kokudo, N., & Makuuchi, M. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.02.091 · Cited by 754
Kojima, K., Takata, A., Vadnais, C., Otsuka, M., Yoshikawa, T., Akanuma, M., Kondo, Y., Kang, Y. J., Kishikawa, T., Kato, N., et al. (2011) · Nature Communications · doi:10.1038/ncomms1345 · Cited by 717
Kennedy, A., Nag, S., Salem, R., Murthy, R., McEwan, A. J., Nutting, C., Benson, A., Espat, J., Bilbao, J. I., Sharma, R. A., et al. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2006.11.060 · Cited by 676
Self-citationHussain, S. P., Schwank, J., Staib, F., Wang, X. W., & Harris, C. C. (2007) · Oncogene · doi:10.1038/sj.onc.1210279 · Cited by 621
Mazzaferro, V., Bhoori, S., Sposito, C., Bongini, M., Langer, M., Miceli, R., & Mariani, L. (2011) · Liver Transplantation · doi:10.1002/lt.22365 · Cited by 593
Lin, S.-M., Lin, C.-J., Lin, C.-C., Hsu, C.-W., & Chen, Y.-C. (2005) · Gut · doi:10.1136/gut.2004.045203 · Cited by 592 · cited 1×
“In one study, PEIT was effective in only 50% of patients with multinodular or large (3–5 cm) HCC; in addition, tumor progression was seen in almost 33% of HCC of more than 3 cm despite several treatment courses.(64) HCC size is a very important factor in the selection of locoregional therapy, such as RFA.”
BackgroundYeo, W., Mok, T. S., Zee, B., Leung, T. W. T., Lai, P. B. S., Lau, W. Y., Koh, J., Mo, F. K. F., Yu, S. C. H., Chan, A. T., et al. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji315 · Cited by 590
Shibata, T., Iimuro, Y., Yamamoto, Y., Maetani, Y., Ametani, F., Itoh, K., & Konishi, J. (2002) · Radiology · doi:10.1148/radiol.2232010775 · Cited by 575
Focus on hepatocellular carcinoma
Bruix, J., Boix, L., Sala, M., & Llovet, J. M. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00058-3 · Cited by 570
Hepatocellular Carcinoma From Epidemiology to Prevention: Translating Knowledge into Practice
Singal, A. G., & El-Serag, H. B. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.08.014 · Cited by 530
In Vivo Results of a New Focal Tissue Ablation Technique: Irreversible Electroporation
Edd, J. F., Horowitz, L., Davalos, R. V., Mir, L. M., & Rubinsky, B. (2006) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2006.873745 · Cited by 510
Updated treatment approach to hepatocellular carcinoma
Llovet, J. M. (2005) · Journal of Gastroenterology · doi:10.1007/s00535-005-1566-3 · Cited by 508
Li, H., Wu, K., Tao, K., Chen, L., Zheng, Q., Lu, X., Liu, J., Shi, L., Liu, C., Wang, G., et al. (2012) · Hepatology · doi:10.1002/hep.25777 · Cited by 496
Shi, F., Shi, M., Zeng, Z., Qi, R., Liu, Z., Zhang, J., Yang, Y., Tien, P., & Wang, F. (2011) · International Journal of Cancer · doi:10.1002/ijc.25397 · Cited by 464
Hilgard, P., Hamami, M., Fouly, A. E., Scherag, A., Müller, S., Ertle, J., Heusner, T., Cicinnati, V. R., Paul, A., Bockisch, A., et al. (2010) · Hepatology · doi:10.1002/hep.23944 · Cited by 458
Targeted Therapies for Hepatocellular Carcinoma
Villanueva, A., & Llovet, J. M. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.03.006 · Cited by 449
Wang, L., Pino-Lagos, K., de Vries, V. C., Guleria, I., Sayegh, M. H., & Noelle, R. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710441105 · Cited by 389
Liang, P., Wang, Y., Yu, X., & Dong, B. (2009) · Radiology · doi:10.1148/radiol.2513081740 · Cited by 378
Verslype, C., Rosmorduc, O., & Rougier, P. (2012) · Annals of Oncology · doi:10.1093/annonc/mds225 · Cited by 365
Lu, D. S. K., Yu, N. C., Raman, S. S., Lassman, C., Tong, M. J., Britten, C., Durazo, F., Saab, S., Han, S., Finn, R., et al. (2005) · Hepatology · doi:10.1002/hep.20688 · Cited by 355
Pawlik, T. M., Reyes, D. K., Cosgrove, D., Kamel, I. R., Bhagat, N., & Geschwind, J.-F. H. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.37.1021 · Cited by 304
Cancer Cells Ablation with Irreversible Electroporation
Miller, L., Leor, J., & Rubinsky, B. (2005) · Technology in Cancer Research & Treatment · doi:10.1177/153303460500400615 · Cited by 298
DuBay, D., Sandroussi, C., Sandhu, L., Cleary, S., Guba, M., Cattral, M. S., McGilvray, I., Ghanekar, A., Selzner, M., Greig, P. D., et al. (2011) · Annals of Surgery · doi:10.1097/sla.0b013e31820508f1 · Cited by 286
The Ras/MAPK pathway and hepatocarcinoma: pathogenesis and therapeutic implications
Delire, B., & Stärkel, P. (2015) · European Journal of Clinical Investigation · doi:10.1111/eci.12441 · Cited by 275
Vilana, R., Bruix, J., Bru, C., Ayuso, C., Solé, M., & Rodés, J. (1992) · Hepatology · doi:10.1002/hep.1840160212 · Cited by 270
Schadde, E., Raptis, D. A., Schnitzbauer, A. A., Ardiles, V., Tschuor, C., Lesurtel, M., Abdalla, E. K., Hernandez-Alejandro, R., Jovine, E., Machado, M., et al. (2015) · Annals of Surgery · doi:10.1097/sla.0000000000001450 · Cited by 259
Wu, F., Wang, Z.-B., Chen, W.-Z., Zou, J.-Z., Bai, J., Zhu, H., Li, K.-Q., Jin, C.-B., Xie, F.-L., & Su, H.-B. (2005) · Radiology · doi:10.1148/radiol.2352030916 · Cited by 251
McDannold, N., Tempany, C. M., Fennessy, F. M., So, M. J., Rybicki, F. J., Stewart, E. A., Jolesz, F. A., & Hynynen, K. (2006) · Radiology · doi:10.1148/radiol.2401050717 · Cited by 231
Han, Y., Chen, Z., Yang, Y., Jiang, Z., Gu, Y., Liu, Y., Lin, C., Pan, Z., Yu, Y., Jiang, M., et al. (2014) · Hepatology · doi:10.1002/hep.26694 · Cited by 226
Treatment of Prostate Cancer with Transrectal Focused Ultrasound: Early Clinical Experience
Gelet, A., Chapelon, J. Y., Bouvier, R., Souchon, R., Pangaud, C., Abdelrahim, A. F., Cathignol, D., & Dubernard, J. M. (1996) · European Urology · doi:10.1159/000473739 · Cited by 223
Sorafenib for the Treatment of Unresectable Hepatocellular Carcinoma
Kane, R. C., Farrell, A. T., Madabushi, R., Booth, B., Chattopadhyay, S., Sridhara, R., Justice, R., & Pazdur, R. (2009) · The Oncologist · doi:10.1634/theoncologist.2008-0185 · Cited by 221
Current management of hepatocellular carcinoma.
Crissien, A. M., & Frenette, C. T. (2014) · Europe PMC (PubMed Central) · Cited by 215
Takayasu, K., Arii, S., Kudo, M., Ichida, T., Matsui, O., Izumi, N., Matsuyama, Y., Sakamoto, M., Nakashima, O., Ku, Y., et al. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.10.021 · Cited by 214
Josep, M. L., Ducreux, M. P., Riccardo, L., et al. (2012) · European Journal of Cancer · Cited by 195
Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy (ALPPS): Tips and Tricks
Alvarez, F. A., Ardiles, V., Sanchez Claria, R., Pekolj, J., & de Santibañes, E. (2013) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-012-2092-2 · Cited by 194
Current management of hepatocellular carcinoma
Tabrizian, P. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i30.10223 · Cited by 168
Chemotherapy and target therapy for hepatocellular carcinoma: New advances and challenges
Deng, G., Zeng, S., & Shen, H. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i5.787 · Cited by 163
Cescon, M., Cucchetti, A., Ravaioli, M., & Pinna, A. D. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2012.09.021 · Cited by 159
Carcinoma hepatocelular: epidemiologia, biologia, diagnóstico e terapias
Gomes, M. A., Priolli, D. G., Tralhão, J. G., & Botelho, M. F. (2013) · Revista da Associação Médica Brasileira · doi:10.1016/j.ramb.2013.03.005 · Cited by 155
Li, F., Zhang, Y., Jin, G., Yao, L., & Wu, D. (2012) · Immunology Letters · doi:10.1016/j.imlet.2012.12.004 · Cited by 147
Pitton, M. B., Kloeckner, R., Ruckes, C., Wirth, G., Eichhorn, W., Wörns, M., Weinmann, A., Schreckenberger, M., Galle, P. R., Otto, G., et al. (2014) · CardioVascular and Interventional Radiology · doi:10.1007/s00270-014-1012-0 · Cited by 143
Epigenetics in hepatocellular carcinoma: An update and future therapy perspectives
Ma, L., Chua, M.-S., Andrisani, O., & So, S. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i2.333 · Cited by 120
Stephan Madersbacher, A., Schatzl, G., Djavan, B., Stulnig, T. M., & Marberger, M. (2000) · European Urology · doi:10.1159/000020219 · Cited by 119
Should ALPPS be Used for Liver Resection in Intermediate-Stage HCC?
D’Haese, J. G., Neumann, J. H. L., Weniger, M., Pratschke, S., Björnsson, B., Ardiles, V., Chapman, W. C., Hernandez‐Alejandro, R., Soubrane, O., Robles-Campos, R., et al. (2015) · Annals of Surgical Oncology · doi:10.1245/s10434-015-5007-0 · Cited by 117
Updates in the management of hepatocellular carcinoma.
Wong, R. J., & Frenette, C. T. (2011) · PubMed · Cited by 110
Advanced hepatocellular carcinoma. Review of targeted molecular drugs
Rogério, C. P. A., Daniele, A., Guz, B., Carla, M., Monica, V., Harriz, M., Deborah, T., Mario, K., Gampel, O., & Poletti, P. (2011) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31582-0 · Cited by 110
Zhao, Y., Wang, W. J., Guan, S., Li, H., Xu, R. C., Wu, J., Liu, J. S., Li, H. P., Bai, W., Yin, Z., et al. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt072 · Cited by 108
High intensity focused ultrasound for the treatment of rat tumours
ter Haar, G., Rivens, I., Chen, L., & Riddler, S. (1991) · Physics in Medicine and Biology · doi:10.1088/0031-9155/36/11/009 · Cited by 105
Fan, D. N.-Y., Tsang, F. H., Tam, A. H. K., Au, S. L., Wong, C. C., Wei, L., Lee, J. M., He, X., Ng, I. O., & Wong, C. (2012) · Hepatology · doi:10.1002/hep.26083 · Cited by 104
Yang, J. (2012) · Oncology Reports · doi:10.3892/or.2012.1675 · Cited by 99
Bai, W., Wang, Y. J., Zhao, Y., Qi, X., Yin, Z., He, C., Li, R. J., Wu, K., Xia, J. L., Fan, D. M., et al. (2013) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12038 · Cited by 96
DNA methylation, microRNAs, and their crosstalk as potential biomarkers in hepatocellular carcinoma
Anwar, S. L., & Lehmann, U. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i24.7894 · Cited by 88
Liu, C., Liu, L., Shan, J., Shen, J., Xu, Y., Zhang, Q., Yang, Z., Wu, L., Xia, F., Bie, P., et al. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.07.022 · Cited by 86
ALPPS: Challenging the concept of unresectability – A systematic review
Bertens, K. A., Hawel, J. D. E., Lung, K. C., Buac, S., Pineda‐Solís, K., & Hernandez‐Alejandro, R. (2014) · International Journal of Surgery · doi:10.1016/j.ijsu.2014.12.008 · Cited by 81
Future perspectives in hepatocellular carcinoma
Wörns, M., & Galle, P. R. (2010) · Digestive and Liver Disease · doi:10.1016/s1590-8658(10)60521-x · Cited by 76
Emerging Targeted Strategies in Advanced Hepatocellular Carcinoma
Finn, R. (2013) · Seminars in Liver Disease · doi:10.1055/s-0033-1333632 · Cited by 75
Li, Y., Sha, W., Zhou, Y., & Nie, Y. (2006) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04719.x · Cited by 73
Systemic Therapies in Hepatocellular Carcinoma
Wörns, M., Weinmann, A., Schuchmann, M., & Galle, P. R. (2009) · Digestive Diseases · doi:10.1159/000218351 · Cited by 64
Effect of liver regeneration on malignant hepatic tumors
Shi, J., & Line, P. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i43.16167 · Cited by 61
Chen, Z., Shen, S., Peng, B., & Tao, J. (2009) · International Journal of Hyperthermia · doi:10.1080/02656730902976807 · Cited by 58
Hepatocellular Carcinoma and Chemotherapy: The Role of p53
Brito, A., Abrantes, A. M., Pinto-Costa, C., Gomes, A. R., Mamede, A. C., Casalta‐Lopes, J., Gonçalves, A. C., Sarmento‐Ribeiro, A. B., Tralhão, J. G., & Botelho, M. F. (2012) · Chemotherapy · doi:10.1159/000343656 · Cited by 58
Sorafenib: 10 years after the first pivotal trial
Gadaleta‐Caldarola, G., Infusino, S., Divella, R., Ferraro, E., Mazzocca, A., Rose, F. D., Filippelli, G., Abbate, I., & Brandi, M. (2015) · Future Oncology · doi:10.2217/fon.15.85 · Cited by 54
Cao, Y., Fu, Y., Yu, M., Yue, P., Ge, C., Xu, W., Zhan, Y., Li, C., Li, W., Wang, X., et al. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.07.017 · Cited by 51
Understanding the Tumor Suppressor PTEN in Chronic Alcoholism and Hepatocellular Carcinoma
Shearn, C. T., & Petersen, D. R. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-09614-8_10 · Cited by 37
Systemic Therapy for Advanced Hepatocellular Carcinoma: Past, Present, and Future
Giglia, J. L., Antonia, S. J., Berk, L. B., Bruno, S., Dessureault, S., & Finkelstein, S. E. (2010) · Cancer Control · doi:10.1177/107327481001700207 · Cited by 36
Influence of P53 on the radiotherapy response of hepatocellular carcinoma
Gomes, A. R., Abrantes, A. M., Brito, A., Laranjo, M., Casalta‐Lopes, J., Gonçalves, A. C., Sarmento‐Ribeiro, A. B., Botelho, M. F., & Tralhão, J. G. (2015) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2015.21.3.257 · Cited by 31
Detection of Epigenetic Aberrations in the Development of Hepatocellular Carcinoma
Zhang, Y. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-1804-1_37 · Cited by 26
Mansour, L. A., Raziky, M. E., Mohamed, A. A., Mahmoud, E. H., Hamdy, S. A., & Sayed, E. H. E. (2017) · Europe PMC (PubMed Central) · doi:10.22034/apjcp.2017.18.6.1637 · Cited by 20
Cited by
Mechanisms of hepatocellular carcinoma progression
Ogunwobi, O. O., Harricharran, T., Huaman, J., Galuza, A., Odumuwagun, O., Tan, Y., Ma, G. X., & Nguyen, M. T. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i19.2279 · Cited by 291
Gajos-Michniewicz, A., & Czyz, M. (2024) · Genes & Diseases · doi:10.1016/j.gendis.2023.02.050 · Cited by 89
Metadata
- Authors
- Daher, S., Massarwa, M., Benson, A. A., & Khoury, T.
- Venue
- Journal of Clinical and Translational Hepatology
- Publisher
- Xia & He Publishing
- Published
- 2017-12-17
- Volume
- 6
- Issue
- 1
- Pages
- 1-10
- ISSN
- 2225-0719 (ISSN-L)
- 2310-8819
- OpenAlex
- W2774659630
- Cited by
- 304
- References
- 97
- FWCI
- 17.71
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.